These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 34237593)
1. Dexmedetomidine preconditioning mitigates myocardial ischemia/reperfusion injury via inhibition of mast cell degranulation. Xiong W; Zhou R; Qu Y; Yang Y; Wang Z; Song N; Liang R; Qian J Biomed Pharmacother; 2021 Sep; 141():111853. PubMed ID: 34237593 [TBL] [Abstract][Full Text] [Related]
2. Oxytocin ameliorates ischemia/reperfusion-induced injury by inhibiting mast cell degranulation and inflammation in the rat heart. Xiong W; Yao M; Zhou R; Qu Y; Yang Y; Wang Z; Song N; Chen H; Qian J Biomed Pharmacother; 2020 Aug; 128():110358. PubMed ID: 32526456 [TBL] [Abstract][Full Text] [Related]
3. Dexmedetomidine exerts cardioprotective effect through miR-146a-3p targeting IRAK1 and TRAF6 via inhibition of the NF-κB pathway. He L; Wang Z; Zhou R; Xiong W; Yang Y; Song N; Qian J Biomed Pharmacother; 2021 Jan; 133():110993. PubMed ID: 33220608 [TBL] [Abstract][Full Text] [Related]
4. Fluvastatin attenuated ischemia/reperfusion-induced autophagy and apoptosis in cardiomyocytes through down-regulation HMGB1/TLR4 signaling pathway. Ding HS; Yang J; Yang J; Guo X; Tang YH; Huang Y; Chen Z; Fan ZX; Huang CX Mol Biol Rep; 2021 May; 48(5):3893-3901. PubMed ID: 34032975 [TBL] [Abstract][Full Text] [Related]
5. Dexmedetomidine preconditioning for myocardial protection in ischaemia-reperfusion injury in rats by downregulation of the high mobility group box 1-toll-like receptor 4-nuclear factor κB signalling pathway. Yang YF; Peng K; Liu H; Meng XW; Zhang JJ; Ji FH Clin Exp Pharmacol Physiol; 2017 Mar; 44(3):353-361. PubMed ID: 27998004 [TBL] [Abstract][Full Text] [Related]
6. Dexmedetomidine pretreatment protects the heart against apoptosis in ischemia/reperfusion injury in diabetic rats by activating PI3K/Akt signaling in vivo and in vitro. Chang JH; Jin MM; Liu JT Biomed Pharmacother; 2020 Jul; 127():110188. PubMed ID: 32407987 [TBL] [Abstract][Full Text] [Related]
7. Dexmedetomidine-induced cardioprotection is mediated by inhibition of high mobility group box-1 and the cholinergic anti-inflammatory pathway in myocardial ischemia-reperfusion injury. Zhang J; Xia F; Zhao H; Peng K; Liu H; Meng X; Chen C; Ji F PLoS One; 2019; 14(7):e0218726. PubMed ID: 31344138 [TBL] [Abstract][Full Text] [Related]
8. Dexmedetomidine preconditioning may attenuate myocardial ischemia/reperfusion injury by down-regulating the HMGB1-TLR4-MyD88-NF-кB signaling pathway. Zhang JJ; Peng K; Zhang J; Meng XW; Ji FH PLoS One; 2017; 12(2):e0172006. PubMed ID: 28222157 [TBL] [Abstract][Full Text] [Related]
9. Propofol attenuates myocardial ischemia reperfusion injury partly through inhibition of resident cardiac mast cell activation. Yu X; Sun X; Zhao M; Hou Y; Li J; Yu J; Hou Y Int Immunopharmacol; 2018 Jan; 54():267-274. PubMed ID: 29172064 [TBL] [Abstract][Full Text] [Related]
10. Daphnetin Preconditioning Decreases Cardiac Injury and Susceptibility to Ventricular Arrhythmia following Ischaemia-Reperfusion through the TLR4/MyD88/NF-Κb Signalling Pathway. Yang F; Jiang X; Cao H; Shuai W; Zhang L; Wang G; Quan D; Jiang X Pharmacology; 2021; 106(7-8):369-383. PubMed ID: 33902056 [TBL] [Abstract][Full Text] [Related]
11. Mast cell degranulation does not contribute to ischemic preconditioning in isolated rabbit hearts. Wang P; Downey JM; Cohen MV Basic Res Cardiol; 1996; 91(6):458-67. PubMed ID: 8996631 [TBL] [Abstract][Full Text] [Related]
12. Propofol pretreatment alleviates mast cell degranulation by inhibiting SOC to protect the myocardium from ischemia-reperfusion injury. Li Y; Sun X; Juan Z; Guan X; Wang M; Meng Y; Ma R Biomed Pharmacother; 2022 Jun; 150():113014. PubMed ID: 35658248 [TBL] [Abstract][Full Text] [Related]
13. Resident cardiac mast cells and the cardioprotective effect of ischemic preconditioning in isolated rat heart. Parikh V; Singh M J Cardiovasc Pharmacol; 1997 Aug; 30(2):149-56. PubMed ID: 9269940 [TBL] [Abstract][Full Text] [Related]
14. Possible role of adrenergic component and cardiac mast cell degranulation in preconditioning-induced cardioprotection. Parikh V; Singh M Pharmacol Res; 1999 Aug; 40(2):129-37. PubMed ID: 10433871 [TBL] [Abstract][Full Text] [Related]
15. Clemastine Fumarate Attenuates Myocardial Ischemia Reperfusion Injury Through Inhibition of Mast Cell Degranulation. Meng S; Sun X; Juan Z; Wang M; Wang R; Sun L; Li Y; Xin A; Li S; Li Y Front Pharmacol; 2021; 12():704852. PubMed ID: 34512339 [TBL] [Abstract][Full Text] [Related]
16. Dexmedetomidine Preconditioning Ameliorates Inflammation and Blood-Spinal Cord Barrier Damage After Spinal Cord Ischemia-Reperfusion Injury by Down-Regulation High Mobility Group Box 1-Toll-Like Receptor 4-Nuclear Factor κB Signaling Pathway. Liu J; Zhang S; Fan X; Yuan F; Dai J; Hu J Spine (Phila Pa 1976); 2019 Jan; 44(2):E74-E81. PubMed ID: 29975331 [TBL] [Abstract][Full Text] [Related]
17. Dexmedetomidine Preconditioning Protects Cardiomyocytes Against Hypoxia/Reoxygenation-Induced Necroptosis by Inhibiting HMGB1-Mediated Inflammation. Chen J; Jiang Z; Zhou X; Sun X; Cao J; Liu Y; Wang X Cardiovasc Drugs Ther; 2019 Feb; 33(1):45-54. PubMed ID: 30675709 [TBL] [Abstract][Full Text] [Related]
18. Dexmedetomidine preconditioning activates pro-survival kinases and attenuates regional ischemia/reperfusion injury in rat heart. Ibacache M; Sanchez G; Pedrozo Z; Galvez F; Humeres C; Echevarria G; Duaso J; Hassi M; Garcia L; Díaz-Araya G; Lavandero S Biochim Biophys Acta; 2012 Apr; 1822(4):537-45. PubMed ID: 22230708 [TBL] [Abstract][Full Text] [Related]
19. Cardioprotective effect of breviscapine: inhibition of apoptosis in H9c2 cardiomyocytes via the PI3K/Akt/eNOS pathway following simulated ischemia/reperfusion injury. Wang J; Ji SY; Liu SZ; Jing R; Lou WJ Pharmazie; 2015 Sep; 70(9):593-7. PubMed ID: 26492644 [TBL] [Abstract][Full Text] [Related]
20. Minocycline protects against myocardial ischemia/reperfusion injury in rats by upregulating MCPIP1 to inhibit NF-κB activation. Yi Q; Tan FH; Tan JA; Chen XH; Xiao Q; Liu YH; Zhang GP; Luo JD Acta Pharmacol Sin; 2019 Aug; 40(8):1019-1028. PubMed ID: 30792486 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]